3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
38
Carcinoma, Non-Small-Cell Lung
23
Lung Neoplasms
10
Neoplasm Metastasis
7
Hodgkin Disease
6
Recurrence
4
Neoplasms
4
Uterine Cervical Neoplasms
3
Sarcoma
2
Rhabdomyosarcoma
2
Mesothelioma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Carcinoma
2
Breast Neoplasms, Male
2
Brain Neoplasms
2
Triple Negative Breast Neoplasms
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Pleural Effusion, Malignant
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Non - Small Cell Lung Cancer NSCLC
1
Neuroendocrine Tumors
1
Neuralgia
1
Metatropic dwarfism
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Locally Advanced Non-Small Cell Lung Cancer
1
Lethal Congenital Contracture Syndrome 2
1
Glioma
1
Interventions
selpercatinib
2
pralsetinib
2
pembrolizumab
2
Pemetrexed
2
Paclitaxel
2
Carboplatin
2
patritumab
1
osimertinib
1
napabucasin
1
efineptakin alfa
1
durvalumab
1
cobimetinib
1
atezolizumab
1
alectinib
1
Tyrosine Kinase Inhibitors
1
Radiosurgery
1
Proton Therapy
1
Metformin
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dasatinib
1
Cisplatin
1
Bevacizumab
1
Afatinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thoracic Neoplasms
×
Vinorelbine
×
Clear all
No trials found.